Israel, Ontario ink $87m worth of science and tech deals

“Ontario is the ideal location to take innovative ideas from concept to marketplace — we have a competitive corporate tax rate, a strong financial sector and a talented workforce.”

By
May 16, 2016 16:46
Kathleen Wynne.

Ontario Premier Kathleen Wynne.. (photo credit: SONIA CACOILO)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Companies from Israel and Ontario signed 18 deals valued at $87 million in Tel Aviv on Monday, during a visit from Ontario Premier Kathleen Wynne.

“I am pleased that so many Israeli and Ontario companies have created partnerships to develop innovative solutions to real-world scientific and technological challenges,” said Wynne. “Ontario is the ideal location to take innovative ideas from concept to marketplace – we have a competitive corporate tax rate, a strong financial sector and a talented workforce,” she added.

Be the first to know - Join our Facebook page.


The deals focused on science and technology, and included one between Ben-Gurion University of the Negev with Zenyatta Ventures to develop earthquake-resistant concrete and another between Insightec and Ontario’s University Health Network for removing brain tissue non-surgically.

During her visit, Wynne also has met with Michael Hayden, Teva Pharmaceutical’s president of global R&D, “to discuses future business opportunities.”

She is also set to meet with former president Shimon Peres and accept the President’s Award from Tel Aviv University for her promotion of tolerance, inclusion and civil discourse.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Workers strike outside of the Teva building in Jerusalem, December 2017
December 18, 2017
Workers make explosive threats as massive Teva layoff strikes continue

By MAX SCHINDLER